Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck
Journal of clinical oncology, 2009-04, Vol.27 (11), p.1864-1871 [Peer Reviewed Journal]2009 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2008.17.0530
Full text available